| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.81B | 47.39B | 40.71B | 34.95B | 30.58B | 27.53B |
| Gross Profit | 24.34B | 19.52B | 17.09B | 14.15B | 12.57B | 10.31B |
| EBITDA | 17.24B | 13.49B | 11.44B | 9.87B | 8.31B | 6.74B |
| Net Income | 10.39B | 7.78B | 6.19B | 5.43B | 4.21B | 2.98B |
Balance Sheet | ||||||
| Total Assets | 88.14B | 80.61B | 81.56B | 70.89B | 67.67B | 61.68B |
| Cash, Cash Equivalents and Short-Term Investments | 17.74B | 13.44B | 13.73B | 12.83B | 13.97B | 8.07B |
| Total Debt | 23.71B | 18.63B | 22.62B | 21.26B | 21.68B | 23.41B |
| Total Liabilities | 35.18B | 31.80B | 34.47B | 28.91B | 30.38B | 30.21B |
| Stockholders Equity | 52.95B | 48.81B | 47.09B | 41.98B | 37.29B | 31.46B |
Cash Flow | ||||||
| Free Cash Flow | 11.05B | 8.77B | 7.42B | 3.41B | 7.43B | 5.05B |
| Operating Cash Flow | 11.25B | 9.75B | 8.33B | 3.73B | 7.56B | 5.25B |
| Investing Cash Flow | 2.15B | 534.00M | -3.67B | -1.44B | -328.00M | -234.00M |
| Financing Cash Flow | -11.84B | -10.57B | -3.77B | -3.44B | -1.35B | -2.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥702.08B | 28.67 | ― | 1.30% | 25.07% | 26.47% | |
71 Outperform | ¥21.39B | 8.70 | ― | 2.18% | 17.87% | 5.31% | |
66 Neutral | ¥191.29B | 23.86 | ― | 1.19% | 23.88% | 64.21% | |
64 Neutral | ¥31.72B | 31.60 | ― | 4.39% | 2.46% | -31.77% | |
63 Neutral | ¥54.68B | 34.13 | ― | 2.96% | 10.63% | 7.42% | |
63 Neutral | ¥16.31B | 95.88 | ― | ― | 16.77% | 39.98% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |